Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
Aveanna Healthcare Holdings Inc. reported the results of its 2026 Annual Meeting of Stockholders held on May 29, 2026. Stockholders elected three Class II directors—Rodney D. Windley, Sam Weil, and Steven E. Rodgers—to three-year terms ending at the 2029 Annual Meeting.
Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending January 2, 2027, with 198,808,170 votes for and 477,379 against. Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 160,094,458 votes for and 19,490,871 against. No other matters were considered.
Aveanna Healthcare Holdings Inc. announced that its subsidiary Aveanna Healthcare LLC has repriced its first lien credit and revolving credit facilities. The amendment refinances outstanding senior secured term loans with new 2026 Term Loans totaling $1,318,375,000 and renews a $250,000,000 senior secured revolving credit facility.
The 2026 Facilities reduce applicable interest rate margins by 0.50 percentage points. Both the term loans and revolver now bear interest at, at the borrower’s election, Term SOFR plus a 3.25% margin or a base rate plus a 2.25% margin. Margins may be reduced by an additional 0.25 percentage points if the borrower obtains a rating of at least B2 or B from specified credit rating agencies, while other key credit agreement terms remain largely unchanged.
Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported an open-market sale of 125,000 shares of common stock at a weighted average price of $7.5883 per share. The sale occurred on May 20, 2026 and reflects a discretionary transaction in the market.
Following this sale, Cunningham directly holds 212,755 shares of Aveanna common stock. The reported price range for the trades was between $7.50 and $7.69 per share, based on multiple individual transactions combined into the disclosed weighted average price.
AVAH filed a Form 144 reporting proposed sales of Common Stock and listing restricted stock vesting events under a registered plan. The filing lists 125,000 shares alongside a dollar figure $948,537.50 and the entry 217,755,203 with date 05/20/2026. The filing also itemizes restricted stock vesting: 75,406 shares on 06/05/2025, 38,985 shares on 12/29/2025, and 10,609 shares on 02/14/2026, each described as "Restricted stock vesting under a registered plan" and labeled "Services Rendered."
Aveanna Healthcare Holdings Inc. furnished an investor presentation outlining 2026 guidance and strong early-year performance. The company targets $2.56–$2.58 billion in 2026 revenue and $328–$332 million in Adjusted EBITDA, supported by a national platform of 379 locations across 39 states and 29,000 caregivers.
For Q1 2026, revenue reached $647.9 million, up 15.9% year over year, while Adjusted EBITDA rose to $84.4 million, a 25.2% increase. Net income improved to $41.7 million, and operating cash flow turned positive at $4.3 million, a $12.9 million improvement versus Q1 2025.
The presentation highlights segment growth in Private Duty Services, Home Health & Hospice, and Medical Solutions, along with a focus on value-based agreements and preferred payor relationships. Aveanna reports liquidity of $524.8 million against total variable-rate debt of $1,483 million, with interest rate swaps and caps in place, and free cash flow of $(3.8) million for Q1 2026.
Aveanna Healthcare Holdings reported strong first-quarter 2026 results, with revenue of $647.9 million, up 15.9% from $559.2 million a year earlier. Net income rose to $41.7 million from $5.2 million, and diluted earnings per share increased to $0.19 from $0.03.
Growth was broad-based: Private Duty Services revenue grew 16.4%, Home Health & Hospice 17.4%, and Medical Solutions 7.4%. Field contribution improved to $109.6 million, or 16.9% of revenue, helped by lower branch and regional administrative expenses as a percentage of revenue.
The company generated $4.3 million of operating cash flow, ending the quarter with $189.3 million in cash and cash equivalents. Long-term obligations totaled $1.32 billion, primarily 2025 Term Loans accruing interest at 7.42%, and the $165.0 million Securitization Facility carried a 6.26% rate.
Aveanna also advanced its growth strategy with a pending $175.5 million cash acquisition of Family First Holding, LLC, a multi-state pediatric home care provider, expected to close in the second fiscal quarter of 2026 and funded with cash on hand and its Securitization Facility.
Aveanna Healthcare Holdings reported strong results for the three-month period ended April 4, 2026, with revenue of $647.9 million, up 15.9% from $559.2 million a year earlier. Net income rose to $41.7 million from $5.2 million, and diluted EPS increased to $0.19 from $0.03.
Adjusted EBITDA was $84.4 million, a 25.2% increase, and operating income margin improved to 10.7% of revenue. Management raised full-year 2026 guidance, now expecting revenue between $2.56 and $2.58 billion and Adjusted EBITDA between $328 and $332 million, reflecting confidence in ongoing growth across its home care segments.
Aveanna Healthcare Holdings Inc. outlines strong 2025 performance and key voting items for its 2026 annual meeting. The company reports approximately $2.433 billion in revenue and $320.9 million in adjusted EBITDA, up 20.2% and 74.8% year over year. Net cash from operating activities was $125.9 million and free cash flow was $131.0 million for the year ended January 3, 2026. Aveanna completed its three‑year Strategic Transformation, integrated the Thrive Skilled Pediatric Care acquisition, and executed a significant credit facility refinancing to extend maturities and increase liquidity. Stockholders are asked to elect three Class II directors, ratify Ernst & Young LLP as independent auditors for fiscal 2026, and approve an advisory “say on pay” vote on named executive officer compensation, which combines base salary, annual cash incentives and long‑term equity awards.
Aveanna Healthcare Holdings Inc. furnished a March 2026 investor presentation outlining recent performance, capital structure and long‑term growth plans. For Q4 2025, revenue rose from $519.9m to $662.5m, a 27.4% increase, while gross margin grew from $171.7m to $213.3m. Adjusted EBITDA increased from $55.2m to $85.0m, up 54.0%. For full‑year 2025, operating cash flow was $125.9m and free cash flow was $131.0m. The company guided 2026 revenue to $2.54b–$2.56b with Adjusted EBITDA of $318m–$322m, supported by a national platform of 366 locations in 38 states and 29,000 caregivers. Liquidity totaled $528.8m, against $1,487m of variable‑rate debt, partially hedged with swaps and caps. Aveanna highlights value‑based growth across Private Duty Services, Home Health & Hospice, and Medical Solutions, each with targeted organic growth and margin ranges.